New funding for SegueTx
Jared Snider
The New Louisiana Angel Fund pledged investments totaling $170K to SegueTx-Pancreatic Cancer, a subsidiary company of Segue Therapeutics. The seed funding round will close upon capital investments of $500K.
Use the form on the right to contact us.
You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.
123 Street Avenue, City Town, 99999
(123) 555-6789
email@address.com
You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.
News and updates about Segue Therapeutics
The New Louisiana Angel Fund pledged investments totaling $170K to SegueTx-Pancreatic Cancer, a subsidiary company of Segue Therapeutics. The seed funding round will close upon capital investments of $500K.